Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Mise à jour : Il y a 6 ans
Référence : NCT00476931

Femme et Homme

Extrait

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.


Critère d'inclusion

  • Diabetes Mellitus, Type 2 ,Diabetes Mellitus, Type 1 ,Diabetic Polyneuropathy

Liens